Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study (MENOK)

November 3, 2023 updated by: Pauline Kang, The University of New South Wales

Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New South Wales
      • Sydney, New South Wales, Australia, 2052
        • School of Optometry and Vision Science, UNSW
        • Contact:
          • Pauline Kang, PhD
        • Principal Investigator:
          • Pauline Kang, PhD
    • Queensland
      • Kelvin Grove, Queensland, Australia, 4059
        • Optometry and Vision Science, Queensland University of Technology
        • Contact:
          • Emily Pieterse, PhD
    • California
      • Berkeley, California, United States, 94720
        • School of Optometry, University of California, Berkeley
        • Contact:
          • Maria Liu, PhD
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • New England College of Optometry
    • New York
      • New York, New York, United States, 10036
        • State University of New York (SUNY), College of Optometry
        • Contact:
          • Xiaoying Zhu, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Myopic children will be recruited from the university based myopia control clinic.

Description

Inclusion Criteria:

  1. Aged 6 to below 14 years old
  2. Spherical equivalent myopic refractive error greater than -0.50 D
  3. Best corrected logMAR visual acuity of 0.1 or better in each eye
  4. Good ocular and general health that would not preclude them from myopia control
  5. Competent enough in English to fully understand the participant information and consent form
  6. Willing to undergo treatment to slow myopia progression for one year

Exclusion Criteria:

  1. Strabismus at distance or near, amblyopia or significant anisometropia (>1.50 D)
  2. Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis)
  3. Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision
  4. Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development
  5. Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Near viewing duration
Time Frame: 12 months
Duration during near tasks
12 months
Near viewing distance
Time Frame: 12 months
Distance during near tasks
12 months
Outdoor time
Time Frame: 12 months
Ambient illumination to determine time spent outdoors
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective cycloplegic central refraction
Time Frame: 12 months
Change in objective refraction to measure myopia progression
12 months
Axial length
Time Frame: 12 months
Change in axial length to measure myopia progression
12 months
Subjective cycloplegic central refraction
Time Frame: 12 months
Change in subjective refraction to measure myopia progression
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2023

Primary Completion (Estimated)

November 1, 2024

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

October 30, 2023

First Submitted That Met QC Criteria

November 3, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 3, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

3
Subscribe